ALX Oncology Holdings Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VENBIO PARTNERS LLC | 02/14/2025 | 9.70 M | $16.20 M | 0.00% | 18.41% |
REDMILE GROUP, LLC | 02/14/2025 | 3.69 M | $6.16 M | -3.83% | 7.00% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 3.30 M | $5.51 M | -21.59% | 6.26% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.38 M | $3.98 M | -8.36% | 4.52% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.13 M | $3.56 M | 6.33% | 4.04% |
VANGUARD GROUP INC | 02/11/2025 | 1.89 M | $3.15 M | 0.13% | 3.58% |
FMR LLC | 02/13/2025 | 1.85 M | $3.09 M | -68.43% | 3.51% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 1.39 M | $2.32 M | -42.26% | 2.64% |
ALMITAS CAPITAL LLC | 02/14/2025 | 1.22 M | $2.04 M | 100.00% | 2.32% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.11 M | $1.85 M | 160.17% | 2.11% |
BANK OF MONTREAL /CAN/ | 02/13/2025 | 826,582 | $1.38 M | 100.00% | 1.57% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 823,900 | $1.38 M | 64.62% | 1.56% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 740,106 | $1.24 M | 5.60% | 1.40% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 704,131 | $1.18 M | 6.68% | 1.34% |
STATE STREET CORP | 02/14/2025 | 684,123 | $1.14 M | 1.90% | 1.30% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 569,009 | $950,245 | 121.51% | 1.08% |
PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 509,059 | $850,129 | 0.00% | 0.97% |
UBS GROUP AG | 02/14/2025 | 408,056 | $681,454 | 1,295.54% | 0.77% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 301,419 | $503,370 | 16.93% | 0.57% |
XTX TOPCO LTD | 02/13/2025 | 263,856 | $440,640 | -16.85% | 0.50% |
D. E. SHAW & CO., INC. | 02/14/2025 | 255,878 | $427,316 | -11.89% | 0.49% |
JPMORGAN CHASE & CO | 02/12/2025 | 236,046 | $394,197 | 476.65% | 0.45% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 216,707 | $361,901 | -3.81% | 0.41% |
02/14/2025 | 197,680 | $330,126 | 100.00% | 0.38% | |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 164,790 | $275,199 | 55.62% | 0.31% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 151,620 | $253,205 | 399.60% | 0.29% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 138,470 | $231,245 | -69.75% | 0.26% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 125,000 | $208,750 | 100.00% | 0.24% |
BANK OF NOVA SCOTIA | 02/13/2025 | 105,306 | $175,861 | 100.00% | 0.20% |
DEUTSCHE BANK AG\ | 02/14/2025 | 101,113 | $168,859 | 520.97% | 0.19% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 90,003 | $150,305 | 11.97% | 0.17% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 75,000 | $125,250 | 100.00% | 0.14% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 71,730 | $119,789 | 0.00% | 0.14% |
ABRDN PLC | 01/24/2025 | 66,211 | $110,572 | 0.00% | 0.13% |
BARCLAYS PLC | 02/13/2025 | 65,122 | $109,000 | 9.45% | 0.12% |
SEI INVESTMENTS CO | 02/11/2025 | 60,795 | $101,528 | 100.00% | 0.12% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 43,056 | $71,904 | 50.25% | 0.08% |
RHUMBLINE ADVISERS | 01/30/2025 | 42,516 | $70,996 | 0.96% | 0.08% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 41,985 | $70,114 | 47.28% | 0.08% |
NAN FUNG GROUP HOLDINGS LTD | 02/13/2025 | 41,950 | $70,057 | 0.00% | 0.08% |
DEKABANK DEUTSCHE GIROZENTRALE | 01/29/2025 | 41,000 | $443,000 | 0.00% | 0.08% |
02/14/2025 | 38,900 | $64,963 | 100.00% | 0.07% | |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 32,021 | $53,475 | -91.65% | 0.06% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 01/10/2025 | 31,710 | $57,712 | 0.00% | 0.06% |
CITIGROUP INC | 02/12/2025 | 31,436 | $52,499 | 23.03% | 0.06% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 26,233 | $43,789 | -30.32% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 21,800 | $36,406 | 109.62% | 0.04% |
JANE STREET GROUP, LLC | 02/14/2025 | 20,454 | $34,158 | -26.74% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 18,913 | $31,585 | 4.62% | 0.04% |
JSF FINANCIAL, LLC | 01/29/2025 | 17,500 | $29,225 | 100.00% | 0.03% |
ALX Oncology Holdings Inc. institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of ALX Oncology Holdings Inc.. The most heavily invested institutionals were:
venBio Partners LLC: 9.7 M
Redmile Group, LLC: 3.69 M
TANG CAPITAL MANAGEMENT LLC: 3.3 M
BlackRock Funding, Inc. /DE: 2.38 M
MILLENNIUM MANAGEMENT LLC: 2.13 M
VANGUARD GROUP INC: 1.89 M
77.92% of ALX Oncology Holdings Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 41.00 M shares in the last 24 months. This purchase volume represents approximately $73.40 M in transactions.